Board meeting on October 26, 2026 to consider and approve unaudited Q2 and H1 results

Board meeting scheduled for Monday, October 26, 2026.

Thu 8 Oct 2026

Board Meeting Date

Monday, October 26, 2026

Agenda

consider and approve unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026

Trading Window Closure

closed till October 28, 2026

What the company has informed the exchanges

The company has told BSE and NSE that a meeting of its Board of Directors is scheduled to be held on Monday, October 26, 2026.

The main item on the agenda is to consider and approve the company's unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026.

Why a board meeting intimation matters

• It tells you the date on which the next set of financial results is expected to be considered and approved by the board.
• The results cover both the standalone business and the consolidated group, and both the three-month period (quarter) and the six-month period (half year) ended September 30, 2026.
• This intimation is about the meeting and the results date; the revenue, profit and margin figures themselves come with the results, once approved.

Trading window

• In continuation of the company's earlier intimation dated September 25, 2026, the trading window for trading in the securities of the company shall remain closed till October 28, 2026.
• A closed trading window means designated persons covered by the company's insider trading code cannot buy or sell the company's securities during that period. This is a standard practice in the run-up to financial results.

What a reader can take away

• October 26, 2026 is the scheduled date on which the board will consider the unaudited results for the quarter and half year ended September 30, 2026.
• The trading window remains closed till October 28, 2026.
• The notice is also being uploaded on the company's website, www.mankindpharma.com.

Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.